After many discussions and guidance from Dr. Davidson, we opened the first clinical trial specifically in ILC: a biomarker window trial aimed at improving understanding of endocrine therapy in patients with ILC. It was performed with the help of the Translational Breast Cancer Research Consortium (TBCRC). Drs. Rachel Jankowitz and Priscilla McAuliffe are clinical PIs. Dr. Jankowitz received a Career Development Award from Susan G. Komen supporting the study.
Here is the press release: https://www.upmc.com/media/news/100615-invasive-lobular-breast-cancer